All the news Showing 10 of 938 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment issues HIV-positive patients who receive therapy for acute HCV can be cured with just 24 weeks of therapy Michael Carter / 06 June 2011 HIV-positive individuals with acute hepatitis C may be able to clear the infection with just 24 weeks of therapy, Dutch research published in the online edition of AIDS suggests. The retrospective study involved 50 ... Hepatitis A HIV-positive patients have good long-term responses to hepatitis A vaccination Michael Carter / 03 June 2011 HIV-positive patients have a good response to vaccination against hepatitis A virus, US investigators report in the June 15th edition of the Journal of Infectious Diseases. Overall, 85% of patients who had an ... Hepatitis C Gene associated with increased risk of cirrhosis for HIV/HCV-co-infected patients Michael Carter / 24 May 2011 A genetic mutation is associated with an increased risk of cirrhosis for patients co-infected with HIV and hepatitis C, according to Spanish research published in the June 1st edition of the Journal ... Therapies US approval for hepatitis C drug telaprevir Keith Alcorn / 23 May 2011 The US Food and Drug Administration has approved a new hepatitis C drug telaprevir (Incivek), the agency announced today. Telaprevir is a direct-acting antiviral drug (an HCV protease inhibitor), licensed for use in combination ... Therapies European approval recommended for hepatitis C drug boceprevir Keith Alcorn / 23 May 2011 The European Medicines Agency has recommended marketing approval for Merck’s hepatitis C protease inhibitor boceprevir (Victrelis), the agency announced on May 20th. Boceprevir is the first direct-acting antiviral agent for hepatitis C to be ... Treatment issues Genetic variation associated with response to hepatitis C therapy in HIV co-infected patients Michael Carter / 05 May 2011 The presence of a genetic variation in the IL28B gene is associated with better response rates to hepatitis C therapy in patients who are co-infected with HIV and hepatitis C, Spanish investigators ... Treatment issues HIV treatment preserves CD4 cell count during and after HCV therapy in co-infected patients Michael Carter / 03 May 2011 Antiretroviral therapy helps preserve the CD4 cell counts of HIV-positive patients undergoing treatment for hepatitis C, Austrian investigators report in the June 15th edition of the Journal of Infectious Diseases. Treatment with ... HBV vaccination Additional dose of hepatitis B vaccine improves response in patients with HIV Michael Carter / 12 April 2011 Hepatitis B vaccination consisting of four doses produces a better response in HIV-positive patients than the standard three-dose vaccination schedule, French investigators report in the April 13th edition of the Journal of the ... Treatment issues New hepatitis C drugs pose many questions Keith Alcorn / 08 April 2011 Even before new hepatitis C drugs come to market later this year, the vast array of hepatitis C antivirals currently in clinical trials is opening up new horizons for treatment of hepatitis ... Hepatitis C Treatment breaks lead to fibrosis in HIV/HCV-co-infected patients Michael Carter / 07 April 2011 Interrupting HIV therapy is associated with the progression of liver damage in patients co-infected with HIV and hepatitis C, Canadian investigators report in the online edition of AIDS. Taking a break from ... ← Prev1...9091929394Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive